Safety and efficacy of olutasidenib treatment in elderly patients with relapsed/refractory mIDH1 acute myeloid leukemia

被引：0
|
作者：
De Botton, Stephane
Jonas, Brian Andrew
Ferrell, P. Brent
Chao, Mwe Mwe
Mims, Alice S.
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Rigel Pharmaceut Inc, South San Francisco, CA USA
[5] Ohio State Univ, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6527
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax
    Cortes, Jorge
    Jurcic, Joseph
    Baer, Maria R.
    Blum, William
    Brent, Ferrell P., Jr.
    Jonas, Brian A.
    Lee, Sangmin
    Mims, Alice
    Patel, Shyam Ajay
    Schiller, Gary J.
    Yang, Jay
    Watts, Justin M.
    BLOOD, 2023, 142
  • [2] Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia
    De Botton, Stephane
    Yee, Karen
    Recher, Christian
    Wei, Andrew H.
    Montesinos, Pau
    Taussig, David
    Pigneux, Arnaud
    Braun, Thorsten
    Curti, Antonio
    Esteve, Jordi
    Grove, Carolyn
    Jonas, Brian A.
    Khwaja, Asim
    Legrand, Olivier
    Peterlin, Pierre
    Sangerman, Montserrat Arnan
    Blum, William G.
    Cilloni, Daniela
    Hiwase, Devendra
    Jurcic, Joseph G.
    Krauter, Jurgen
    Thomas, Xavier
    Watts, Justin
    Yang, Jay
    Xin, Zihao
    Sedkov, Alex
    Guichard, Sylvie
    Sweeney, Jennifer
    Marzac, Christophe
    Cortes, Jorge E.
    Fenaux, Pierre
    BLOOD, 2021, 138
  • [3] Looking Beyond the Surface: Olutasidenib and Ivosidenib for Treatment of mIDH1 Acute Myeloid Leukemia
    Watts, Justin M.
    Shaw, Simon J.
    Jonas, Brian A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (11) : 1345 - 1353
  • [4] Factors Impacting Response to Olutasidenib in Patients with mIDH1 Acute Myeloid Leukemia
    Wang, Eunice S.
    Jonas, Brian A.
    Watts, Justin M.
    Jurcic, Joseph
    Brent, Ferrell P., Jr.
    Dinner, Shira N.
    Yang, Jay
    Seiter, Karen
    Mims, Alice
    Donnellan, William B.
    Blum, William
    Cortes, Jorge
    BLOOD, 2023, 142
  • [5] Patients with relapsed/refractory mIDH1 AML who proceeded to transplant after olutasidenib treatment
    De Botton, Stephane
    Watts, Justin M.
    Jonas, Brian Andrew
    Chao, Mwe Mwe
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
    Cortes, Jorge E.
    Roboz, Gail J.
    Baer, Maria R.
    Jonas, Brian A.
    Schiller, Gary J.
    Yee, Karen
    Ferrell, P. Brent
    Yang, Jay
    Wang, Eunice S.
    Blum, William G.
    Mims, Alice
    Tian, Hua
    Sheppard, Aaron
    de Botton, Stephane
    Montesinos, Pau
    Curti, Antonio
    Watts, Justin M.
    Olutasidenib Combination Therapy Study Grp
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2025, 18 (01)
  • [7] Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)
    Cortes, Jorge
    Jonas, Brian A.
    Schiller, Gary
    Mims, Alice
    Roboz, Gail J.
    Wei, Andrew H.
    Montesinos, Pau
    Ferrell, P. Brent
    Yee, Karen W. L.
    Fenaux, Pierre
    Schwarer, Anthony
    Watts, Justin M.
    LEUKEMIA & LYMPHOMA, 2024, 65 (08) : 1145 - 1152
  • [8] Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia
    Cortes, Jorge E.
    Esteve, Jordi
    Bajel, Ashish
    Yee, Karen
    Braun, Thorsten
    De Botton, Stephane
    Peterlin, Pierre
    Recher, Christian
    Thomas, Xavier
    Watts, Justin
    Sangerman, Montserrat Arnan
    Curti, Antonio
    Grove, Carolyn
    Jonas, Brian A.
    Lanza, Francesco
    Legrand, Olivier
    Montesinos, Pau
    Patel, Prapti
    Prebet, Thomas
    Wang, Eunice S.
    Polyanskaya, Olga
    Brevard, Julie
    Sweeney, Jennifer
    Fenaux, Pierre
    Wei, Andrew H.
    BLOOD, 2021, 138
  • [9] Olutasidenib in post-venetoclax patients with mIDH1 AML
    Cortes, Jorge E.
    Schiller, Gary J.
    Numerof, Robert
    Floryk, Daniel
    Jonas, Brian Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia
    Cortes, Jorge E.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 211 - 221
12345